Sign In
Buy CGEN
$2.34
-0.0700 (-2.90%)
At Close: Aug 10, 2026
Compugen Doses First Patient In COM701 Phase 1 Monotherapy Expansion Cohort
11:11am, Wednesday, 27'th May 2020Compugen Doses First Patient in COM701 Phase 1 Monotherapy Expansion Cohort
11:00am, Wednesday, 27'th May 2020
Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today announced that the first patient has been dosed in the monotherapy expans
2 Top Biotech Picks for May
11:02am, Wednesday, 20'th May 2020
The art of biotech investing requires a great deal of scientific knowledge, awareness of financials, and patience in waiting for clinical trials to come to fruition. Today, let's examine two of the b
Is the Options Market Predicting a Spike in Compugen (CGEN) Stock?
12:46pm, Monday, 18'th May 2020
Investors need to pay close attention to Compugen (CGEN) stock based on the movements in the options market lately.
Is the Options Market Predicting a Spike in Compugen (CGEN) Stock?
12:00am, Monday, 18'th May 2020How Compugen (CGEN) Stock Stands Out in a Strong Industry
01:48pm, Wednesday, 13'th May 2020
Compugen (CGEN) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
We're Not Very Worried About Compugen's (NASDAQ:CGEN) Cash Burn Rate
06:39pm, Friday, 08'th May 2020
There's no doubt that money can be made by owning shares of unprofitable businesses. By way of example, Compugen...
Top Ranked Momentum Stocks to Buy for May 8th
02:52pm, Friday, 08'th May 2020
Top Ranked Momentum Stocks to Buy for May 8th
